Our analysis of the DepMap database revealed that low micromolar concentrations of epacadostat increased the growth of most ovarian cancer cell lines, providing additional confirmation that IDO1 inhibition alone is insufficient to reduce tumor cell growth without corresponding targeting of TDO2. Here, TDO2 is linked to ovarian carcinoma.